TEM vs HUM
diagnostics · Humana
| TEM diagnostics Healthcare | HUM Humana Healthcare | |
|---|---|---|
| Market | ||
| Price | $81.56 +3.92% | $412.37 +0.48% |
| Market cap | $13.2B | $48.9B |
| P/E (TTM) | — | 38.2 |
| Dividend yield | — | 0.68% |
| 52-week range | $40.77 – $91.83 | $163.11 – $456.50 |
| Our research | ||
| Our view | LONG open | LONG open |
| Articles | 1 | 1 |
| Latest article | Tempus Grew Revenue 23%, But A $42.8 Million Securities Gain Helped The Loss Nov 3, 2026 | Humana’s 22% Medicare Advantage Membership Growth Is Being Dismissed As A Liability — The… Jul 10, 2026 |
| Latest earnings | ||
| Reported | — | — |
| Revenue | — | — |
| EPS | — | — |
| Guidance | — | — |
| Revenue growth, last 4 reports | — | — |
| Topics | ||
| Main topics | ||
| Company page | Company page | |
Note. Earnings figures are extracted automatically from each company's own release; prices are delayed up to 15 minutes. This comparison is information, not investment advice.